Related Experiment Video
Updated: Jan 3, 2026
Live Cell Imaging of Alphaherpes Virus Anterograde Transport and Spread
Published on: August 16, 2013
Microtubule-dependent transport of arenavirus matrix protein demonstrated using live-cell imaging microscopy
Yuki Takamatsu1,2, Junichi Kajikawa1, Yukiko Muramoto1
1Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Japan.
Abstract:
Lassa virus (LASV), belonging to the family Arenaviridae, causes severe haemorrhagic manifestations and is associated with a high mortality rate in humans. Thus, it is classified as a biosafety level (BSL)-4 agent. Since countermeasures for LASV diseases are yet to be developed, it is important to elucidate the molecular mechanisms underlying the life cycle of the virus, including its viral and host cellular protein interactions. These underlying molecular mechanisms may serve as the key for developing novel therapeutic options. Lymphocytic choriomeningitis virus (LCMV), a close relative of LASV, is usually asymptomatic and is categorized as a BSL-2 agent. In the present study, we visualized the transport of viral matrix Z protein in LCMV-infected cells using live-cell imaging microscopy. We demonstrated that the transport of Z protein is mediated by polymerized microtubules. Interestingly, the transport of LASV Z protein showed characteristics similar to those of Z protein in LCMV-infected cells. The live-cell imaging system using LCMV provides an attractive surrogate measure for studying arenavirus matrix protein transport in BSL-2 laboratories. In addition, it could be also utilized to analyze the interactions between viral matrix proteins and the cellular cytoskeleton, as well as to evaluate the antiviral compounds that target the transport of viral matrix proteins.
Insights
Researchers visualized Lassa virus (LASV) Z protein transport using Lymphocytic choriomeningitis virus (LCMV) as a surrogate. This live-cell imaging method in BSL-2 labs aids in studying LASV and developing antiviral therapies.
Area of Science:
- Virology
- Cell Biology
- Microbiology
Background:
- Lassa virus (LASV) is a Biosafety Level (BSL)-4 agent causing severe hemorrhagic fever with high mortality.
- Effective countermeasures for LASV are lacking, necessitating research into its molecular mechanisms.
- Lymphocytic choriomeningitis virus (LCMV), a related BSL-2 agent, serves as a safer model for studying arenaviruses.
Purpose of the Study:
- To visualize and characterize the transport of the viral matrix Z protein in infected cells.
- To investigate the role of cellular microtubules in viral protein transport.
- To establish a BSL-2 surrogate system for studying LASV Z protein transport.
Main Methods:
- Live-cell imaging microscopy was employed to observe viral Z protein dynamics.
- Infected cells with Lymphocytic choriomeningitis virus (LCMV) were utilized as a model system.
- The involvement of polymerized microtubules in Z protein transport was assessed.
Main Results:
- Viral Z protein transport was successfully visualized in real-time using live-cell imaging.
- The study confirmed that polymerized microtubules mediate the transport of the Z protein.
- Lassa virus (LASV) Z protein transport exhibited similar characteristics to LCMV Z protein transport.
Conclusions:
- Live-cell imaging of LCMV Z protein provides a valuable surrogate for studying arenavirus matrix protein transport in BSL-2 settings.
- This approach facilitates the analysis of viral-cytoskeletal interactions.
- The system can be used to screen and evaluate antiviral compounds targeting viral matrix protein transport.
